Clinical Characteristics of Early‐Onset Gout in Outpatient Setting

• Published in: ACR open rheumatology Vol. 1; no. 7; pp. 397 - 402
• Main Authors: Li, Yan, Piranavan, Paramarajan, Sundaresan, Devi, Yood, Robert
• Format: Journal Article
• Language: English
• Published: United States John Wiley and Sons Inc 01-09-2019; Wiley
• Subjects: Original
• ISSN: 2578-5745; 2578-5745
• DOI: 10.1002/acr2.11057

Objective
The objective of this study is to investigate the clinical characteristics and treatment of patients with early‐onset gout.
Methods
We retrospectively reviewed 327 adult patients with a first diagnosis of gout from 2008 to 2016 using the database of a multispecialty group practice in New England. Patients were classified into the following groups: age 30 years or younger at first diagnosis (group 1), age 31‐40 years (group 2), and age over 40 years (group 3). The clinical characteristics and treatment of gout were compared among the three groups.
Results
We identified 87 patients in group 1 and 140 patients in group 2. Group 3 included 100 patients randomly chosen from the 7216 patients with a first diagnosis at age over 40 years. Patients within group 1 had significantly higher serum uric acid (sUA) levels at the time of diagnosis and a more prominent family history of gout. Younger patients (groups 1 and 2) had a significantly higher body mass index than patients over 40 years of age (group 3). A substantial number of younger patients also had hypertension or hyperlipidemia. The majority of younger patients met the 2012 American College of Rheumatology (ACR) guidelines for initiating urate‐lowering therapy (ULT) on the basis of frequency of gout attacks, whereas the majority of patients over 40 years of age met the guidelines for ULT on the basis of chronic kidney disease. Patients over 40 years of age were more likely to achieve an sUA level less than 6.0 mg/dl.
Conclusion
Patients with a first diagnosis of gout at age 40 years or younger frequently had cardiovascular risk factors and were less likely to achieve an sUA level less than 6.0 mg/dl compared with patients over 40 years of age who were treated in routine clinical practice. Clinicians should be aware that patients with early‐onset gout may be an undertreated population with poor adherence to ULT and increased risk of recurrent gout and cardiovascular diseases.